Loading...
•
Dec 31, 2025
Bio-Techne Q2 2026 Earnings Report
Bio-Techne reported flat revenue growth and increased GAAP and adjusted EPS for the second quarter of fiscal year 2026.
Key Takeaways
Bio-Techne announced its second quarter fiscal year 2026 results, with revenue remaining flat at $295.9 million compared to the prior year. The company saw an increase in GAAP EPS to $0.24 and adjusted EPS to $0.46, driven by productivity initiatives and strong commercial execution in the China/APAC region.
Second quarter revenue was $295.9 million, showing flat reported and organic growth year-over-year.
GAAP earnings per share increased to $0.24, up from $0.22 in the prior year, while adjusted EPS rose to $0.46 from $0.42.
Adjusted operating margin improved by 100 basis points to 31.1% due to ongoing productivity and cost containment initiatives.
The China/APAC region experienced growth for the third consecutive quarter, attributed to strong commercial execution and improving end-markets.
Revenue by Segment
Forward Guidance
The company anticipates continued execution in a stabilizing operating environment, with ongoing growth in large pharma and Asia, and continued stabilization among U.S. academic customers.
Positive Outlook
- Continued double-digit growth in the large pharma end market for the fourth consecutive quarter.
- Improving performance in biotech.
- Continued stabilization among U.S. academic customers.
- Ongoing growth in Asia.
- Celebration of Bio-Techne's 50th anniversary in 2026, highlighting a durable and differentiated portfolio.
Challenges Ahead
- The press release does not provide specific negative forward-looking guidance.
- Potential risks and uncertainties inherent in forward-looking statements, as outlined in the Private Securities Litigation Reform Act.
- Impact of foreign currency exchange rate fluctuations.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...